Linda Van Le - Concepedia

Author

Linda Van Le

University of North Carolina at Chapel Hill ORCID

Also Known As

Barber, Emma L., Boardman, Cecelia H., Brady, William E., Coleman, Robert L., DiSilvestro, Paul, Evelyn Fleming, Hanjani, Parviz, Homesley, Howard D., Horick, Nora K., L Van Le

189

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill Gynecologic Oncology Group Roswell Park Comprehensive Cancer Center University of Oklahoma The University of Texas MD Anderson Cancer Center

About

Linda Van Le is an author at University of North Carolina at Chapel Hill specializing in medicine, oncology, and gynecology oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	35	1.5K
2	Health Sciences	3	3	79
3	Public Health	3	3	225
4	Engineering	1	1	37
5	Nursing	1	1	34

Linda Van Le

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Integrated genomic characterization of endometrial carcinoma Gad Getz, Stacey Gabriel, Kristian Cibulskis, Carolina Digital Repository (University of North Carolina at Chapel Hill)	2013	414
Lymphatic Mapping and Sentinel Lymph Node Biopsy in Women With Squamous Cell Carcinoma of the Vulva: A Gynecologic Oncology Group Study Charles F. Levenback, Shamshad Ali, Robert L. Coleman, Journal of Clinical Oncology	2012	385
Uterine serous and grade 3 endometrioid carcinomas David M. Boruta, Paola A. Gehrig, Pamela A. Groben, Cancer	2004	129
Pathologic Findings at Risk-Reducing Salpingo-Oophorectomy: Primary Results From Gynecologic Oncology Group Trial GOG-0199 Mark E. Sherman, Marion Piedmonte, L. Phuong, Journal of Clinical Oncology	2014	128
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study Gini F. Fleming, Virginia L. Filiaci, Brandon Marzullo, Gynecologic Oncology Megestrol AcetateMedicineGynecologyEndometrial CancerOncology	2014	119
Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II Maaike H.M. Oonk, Brian M. Slomovitz, Peter Baldwin, Journal of Clinical Oncology	2021	114
Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study Alessandro D. Santin, Michael W. Sill, D. Scott McMeekin, Gynecologic Oncology Cervical Cancer ManagementCervical CancerPhase Ii TrialNon-squamous Cell CarcinomaMedicine	2011	108
Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group Jubilee Brown, William E. Brady, Julian C. Schink, Cancer	2013	106
Retrograde pedal access for patients with critical limb ischemia Hernan A. Bazán, Linda Van Le, Melissa Donovan, Journal of Vascular Surgery MedicineLower Limb TraumaVascular SurgeryVascular AccessRetrograde Pedal Access	2014	106
Lymph Node Metastases and Prognosis in Patients with Stage IA2Cervical Cancer S.L. Buckley, Denise M. Tritz, Linda Van Le, Gynecologic Oncology Surgical OncologySquamous Cell CarcinomaCancer ManagementPathologySurgery	1996	103

Page 1